Wealth Enhancement Advisory Services LLC Purchases 3,410 Shares of iShares Biotechnology ETF $IBB

Wealth Enhancement Advisory Services LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 9.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,724 shares of the financial services provider’s stock after purchasing an additional 3,410 shares during the period. Wealth Enhancement Advisory Services LLC owned 0.08% of iShares Biotechnology ETF worth $6,644,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Wedmont Private Capital bought a new position in iShares Biotechnology ETF during the fourth quarter worth about $246,000. Magnus Financial Group LLC lifted its position in shares of iShares Biotechnology ETF by 10.2% in the fourth quarter. Magnus Financial Group LLC now owns 6,668 shares of the financial services provider’s stock valued at $1,125,000 after buying an additional 616 shares during the last quarter. Harbor Investment Advisory LLC boosted its stake in shares of iShares Biotechnology ETF by 83.4% during the 4th quarter. Harbor Investment Advisory LLC now owns 2,942 shares of the financial services provider’s stock worth $497,000 after acquiring an additional 1,338 shares during the period. Next Level Private LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $201,000. Finally, TCP Asset Management LLC bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $203,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 2.9%

IBB stock opened at $160.41 on Friday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64. The company has a fifty day moving average price of $171.17 and a two-hundred day moving average price of $164.21.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.